Cancer Letters
Volume 227, Issue 1 , Pages 39-48 , 8 September 2005

Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid

  • K. Melancon

      Affiliations

    • Department of Transplantation and Surgery, Mayo Clinic, Rochester, MN 555905, USA
    • Department of Surgery, New Orleans, LA 70112, USA
    • Tulane Cancer Center, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    • ,
  • Q. Cheng

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • T.L. Kiefer

      Affiliations

    • Molecular and Cellular Biology Graduate Program, New Orleans, LA 70112, USA
    • ,
  • J. Dai

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • L. Lai

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • C. Dong

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • L. Yuan

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • A. Collins

      Affiliations

    • Department of Structural and Cellular Biology, New Orleans, LA 70112, USA
    • ,
  • A. Thiyagarajah

      Affiliations

    • Department of Environmental Health Sciences, New Orleans, LA 70112, USA
    • ,
  • S. Long

      Affiliations

    • Department of Surgery, New Orleans, LA 70112, USA
    • Tulane Cancer Center, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    • ,
  • S.M. Hill

      Affiliations

    • Department of Surgery, New Orleans, LA 70112, USA
    • Molecular and Cellular Biology Graduate Program, New Orleans, LA 70112, USA
    • Tulane Cancer Center, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    • Corresponding Author InformationCorresponding author. Address: Tulane Cancer Center, Molecular and Cellular Biology Grad., Tulane University Health Sciences Center, New Orleans, LA 70112, USA. Tel.: +1 504 988 6456; fax: +1 504 988 1687.

Received 18 August 2004 ,Accepted 7 January 2005.

References 

  1. Lippman ME, Bolan G. Estrogen responsive human breast cancer in continuous tissue culture. Nature (Lond.). 1975;256:592–593
  2. McGuire WL. Hormone receptors; their role in predicting prognosis and response to endocrine therapy. Semin. Oncol. 1978;5:428–433
  3. McGuire WL, Osborne CK, Clark GM, Knight WA. Steroid hormone receptors and carcinoma of the breast. Am. J. Physiol. 1982;243:E99–E102
  4. Osborne CK. Tamoxifen in the treatment of breast cancer. N. Engl. J. Med. 1988;339:1609–1618
  5. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. Melatonin inhibition and pinealectomy enhancement of 7–12 dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res. 1981;41:4432–4436
  6. Blask DE, Hill SM, Orstead KM, Massa JS. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzantracene (DMBA)-induced mammary tumorigenesis. J. Neural Transm. 1986;67:125–138
  7. Blask DE, Leadem CA, Richardson BA. Nutritional status, time of day and pinealectomy: factors influencing the sensitivity of the neuroendocrine-reproductive axis of the rat to melatonin. Horm. Res. 1981;14:104–113
  8. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 1988;48:6121–6126
  9. Cos S, Blask DE. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cancer Lett. 1990;50:115–119
  10. Cos S, Blask DE, Lemus-Wilson A, Hill SM. Effects of melatonin on the cell cycle kinetics and estrogen-rescue of MCF-7 human breast cancer cells in culture. J. Pineal Res. 1991;10:36–42
  11. Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett. 1992;64:249–256
  12. Molis TM, Spriggs LL, Hill SM. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 1994;8:1683–1690
  13. Ram PT, Kiefer T, Silverman M, Song Y, Brown GM, Hill SM. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 1998;141:53–64
  14. Kiefer TL, Yuan L, Ram PT, Hill SM. Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 2002;71:37–45
  15. Rato AG, Pedrero JG, Martinez MA, Del Rio B, Lazo PS, Ramos S. Melatonin blocks the activation of estrogen receptor for DNA binding. Fed. Am. Soc. Exp. Biol. J. 1999;13:857–868
  16. Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM. MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol. Cell. Endocrinol. 2002;192:147–156
  17. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella FJ. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl Acad. Sci. USA. 1995;92:8734–8738
  18. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach J-H, Saurat C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 1994;269:28531–28534
  19. Dai J, Kiefer T, Yuan L, Hill SM. Retinoid orphan receptor-alpha expression in human breast cancer and modulation of their transcriptional activity by the pineal hormone melatonin. Mol. Cell. Endorinol. 2001;176:111–120
  20. Becker-Andre M, Schaeren-Wiemers N, Andre E. Additions and corrections to: pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 1997;272:16707
  21. Lotan R. Retinoids in cancer chemoprevention. Fed. Am. Soc. Exp. Biol. J. 1996;10:1031–1039
  22. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear orphan receptors. Nature (Lond.). 1987;330:444–450
  23. Lammer EJ, Chen DT, Hoar RM, Angish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N. Engl J. Med. 1985;313:837–841
  24. Armstrong RB, Ashenfelter KO, Eckhoff C, Levin AA, Shapiro SS. General and reproductive toxicology of retinoids. In:  Sporn MB,  Roberts AB,  Goodman DS editor. The Retinoids: Biology, Chemistry, and Medicine. New York: Raven Press; 1994;p. 545–572
  25. Eck KM, Yuan L, Duffy L, Ram PT, Ayettey S, Chen I, et al. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br. J. Cancer. 1998;77:2129–2137
  26. Teplitzky SR, Kiefer TL, Cheng Q, Dwivedi PD, Moroz K, Myers L, et al. Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett. 2001;168:155–163
  27. Zhang X, Pfahl M. Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol. Metab. 1993;4:156–162
  28. Sass J, Masgrau E, Saurat J. Metabolism of oral 9-cis-retinoic acid in human: identification of 9-cis-retinoyl-beta glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites. Drug Metab. Dispos. 1995;23:887–891
  29. Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 2000;61:229–239
  30. Brown AMC, Jeltsch JM, Roberts M, Chambon P. Activation of pS2 gene transciption is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl Acad. Sci. USA. 1994;81:6344–6348
  31. Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, et al. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 2002;179:141–150
  32. Ahlersova E, Ahlers I, Kubatka P, Bojkova B, Mocikova K, Gajdosova S, et al. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcionogenesis in female Sprague–Dawley rats. Folia Biol. (Praha). 2000;46:69–72
  33. Benítez-King G, Huerto-Delgadillo L, Antón-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 1993;53:201–207
  34. Teixeira C, Reed JC, Pratt MAC. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995;55:3902–3907

PII: S0304-3835(05)00043-1

doi: 10.1016/j.canlet.2005.01.005

Cancer Letters
Volume 227, Issue 1 , Pages 39-48 , 8 September 2005

Article Tools

* Image Usage & Resolution